Quantifying hepatic arterial blood flow with 4D flow MRI: an in vivo feasibility and repeatability study
Magnetic Resonance Materials in Physics, Biology and Medicine · 14.02.2026 · 39 (5) · 709-722
DOI: 10.1007/s10334-026-01331-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance Materials in Physics, Biology and Medicine, online erschienen am 14.02.2026. Verfasst von Anne van den Brekel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands. Anne.vandenBrekel@radboudumc.nl. Hauptthemen laut MEDLINE: Hepatic Artery, Magnetic Resonance Imaging, Magnetic Resonance Angiography, Imaging, Three-Dimensional. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting voor de Technische Wetenschappen.
Abstract (Originalsprache)
Objective
To investigate the feasibility and repeatability of four-dimensional (4D) flow MRI for quantifying hepatic arterial blood flow (HABF) in healthy volunteers and patients with liver disease, and to identify sources of measurement variability. Materials and methods In this prospective single-centre study, 23 healthy volunteers and 12 patients underwent two-dimensional (2D) and 4D flow acquisitions at 3T. Time-averaged and peak systolic vessel areas, velocities, and flow rates of the common hepatic artery (CHA) were extracted. Feasibility of 4D flow was assessed via CHA visibility on phase-contrast MRA. Scan-rescan repeatability of 4D flow was assessed by calculating within-subject coefficient of variation (CV within ) using two-level variance components analysis (VCA). Within-subject variance was further decomposed into acquisition-related and plane positioning components using three-level VCA. Agreement between 2D and 4D flow was evaluated using Bland–Altman analysis and Pearson’s correlation.
Results
Average 4D flow feasibility rate was 83%. CV within ranged from 12–30%, with acquisition-related factors and plane positioning accounting for 30–40% and 7–11%, respectively. 4D flow overestimated vessel area by ~ 18% and underestimated velocity and flow rate by ~ 53% and ~ 36%, respectively, compared to 2D flow.
Discussion
4D flow MRI enables HABF quantification, though substantial scan-rescan variability exists. Acquisition-related factors were the main source of within-subject variability, while plane positioning contributed less.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands. Anne.vandenBrekel@radboudumc.nl.
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
- Research and Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany.
- MR R&D, Siemens Healthineers USA, Malvern, PA, USA.
Förderung
- Stichting voor de Technische Wetenschappen
Zitieren
APA
van den Brekel, A., Maas, M. C., Spenkelink, I. M., van Tilburg, W. C. M., Roosen, J., Giese, D., Jin, N., Fütterer, J. J., & Nijsen, J. F. W. (2026). Quantifying hepatic arterial blood flow with 4D flow MRI: an in vivo feasibility and repeatability study. Magnetic Resonance Materials in Physics, Biology and Medicine, 39(5), 709-722. https://doi.org/10.1007/s10334-026-01331-0
Vancouver
van den Brekel A, Maas MC, Spenkelink IM, van Tilburg WCM, Roosen J, Giese D, et al. Quantifying hepatic arterial blood flow with 4D flow MRI: an in vivo feasibility and repeatability study. Magnetic Resonance Materials in Physics, Biology and Medicine. 2026;39(5):709-722. doi:10.1007/s10334-026-01331-0
BibTeX
@article{vandenBrekel2026,
author = {van den Brekel, Anne and Maas, Marnix C and Spenkelink, Ilse M and van Tilburg, Willem C M and Roosen, Joey and Giese, Daniel and Jin, Ning and Fütterer, Jurgen J and Nijsen, J Frank W},
title = {Quantifying hepatic arterial blood flow with 4D flow MRI: an in vivo feasibility and repeatability study},
journal = {Magnetic Resonance Materials in Physics, Biology and Medicine},
year = {2026},
volume = {39},
number = {5},
pages = {709--722},
doi = {10.1007/s10334-026-01331-0}
}
EUVIMED